TherapeuticsMD, Inc. Other Non-Current Liabilities
TherapeuticsMD, Inc. (TXMD) had Other Non-Current Liabilities of $873.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-11
- 2026-06-30: Other Liabilities, Noncurrent $873.00K.
- 2026-03-31: Other Liabilities, Noncurrent $873.00K.
- 2025-12-31: Other Liabilities, Noncurrent $873.00K.
- 2025-09-30: Other Liabilities, Noncurrent $871.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $873.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $873.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $873.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $871.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $832.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $795.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $744.00K 10-K/A · filed 2026-04-01 |
| 2024-06-30 | $637.00K 10-Q · filed 2024-08-12 |
| 2023-12-31 | $636.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $1.19M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.19M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.11M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.11M 10-K · filed 2024-03-29 |
| 2022-09-30 | $554.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $554.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $1.23M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $2.14M 10-K · filed 2023-04-07 |
| 2021-09-30 | $758.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $358.00K 10-Q · filed 2021-08-04 |
| 2020-09-30 | $35.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $35.00K 10-Q · filed 2020-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |